Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 16, 2022

SELL
$225.82 - $368.51 $1.2 Million - $1.95 Million
-5,300 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $288,470 - $629,811
1,300 Added 32.5%
5,300 $2.04 Million
Q2 2021

Aug 11, 2021

SELL
$129.91 - $234.98 $4.03 Million - $7.28 Million
-31,000 Reduced 88.57%
4,000 $940,000
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $1.64 Million - $4.25 Million
25,000 Added 250.0%
35,000 $3.66 Million
Q2 2020

Aug 14, 2020

BUY
$29.67 - $80.0 $296,700 - $800,000
10,000 New
10,000 $642,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.